0001437749-19-006476.txt : 20190403
0001437749-19-006476.hdr.sgml : 20190403
20190403163025
ACCESSION NUMBER: 0001437749-19-006476
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190401
FILED AS OF DATE: 20190403
DATE AS OF CHANGE: 20190403
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Linn Stefan C
CENTRAL INDEX KEY: 0001604050
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 19729385
MAIL ADDRESS:
STREET 1: C/O OXFORD IMMUNOTEC GLOBAL
STREET 2: 940 INNOVATION DRIVE
CITY: MILTON PARK ABINGDON
STATE: X0
ZIP: OX14 4RZ
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
4
1
rdgdoc.xml
FORM 4
X0306
4
2019-04-01
0001586049
Oxford Immunotec Global PLC
OXFD
0001604050
Linn Stefan C
C/O OXFORD IMMUNOTEC GLOBAL PLC
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
1
Chief Operating Officer
Ordinary Shares
2019-04-01
4
A
0
20901
0
A
59066
D
Share Option (Right to Buy)
16.42
2019-04-01
4
A
0
44853
0
A
2029-04-01
Ordinary Shares
44853
44853
D
Options granted under Issuer's 2013 Share Incentive Plan.
Options will become exercisable ratably on the anniversary of the vesting start date from January 1, 2020 through January 1, 2023.
/s/ Elizabeth M. Keiley, as Attorney-in-Fact
2019-04-03